Patents by Inventor Jennifer Riggs-Sauthier

Jennifer Riggs-Sauthier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oligome-cannabinoid conjugates
    Patent number: 8829043
    Abstract: The invention relates to (among other things) oligomer-cannabinoid conjugates and related compounds. A conjugate of the invention, when administered by any of a number of administration routes, exhibits advantages over previously administered un-conjugated cannabinoid compounds.
    Type: Grant
    Filed: February 6, 2009
    Date of Patent: September 9, 2014
    Assignee: Nektar Therapeutics
    Inventors: Jennifer Riggs-Sauthier, C. Simone Jude-Fishburn, Guy Lalonde
  • Oligomer-protein tyrosine kinase inhibitor conjugates
    Patent number: 8816077
    Abstract: The invention relates to (among other things) oligomer-PTK inhibitor conjugates and related compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits advantages over PTK inhibitor compounds lacking a water soluble, non peptidic oligomer.
    Type: Grant
    Filed: April 19, 2010
    Date of Patent: August 26, 2014
    Assignee: Nektar Therapeutics
    Inventors: Jennifer Riggs-Sauthier, Wen Zhang
  • Oligomer-corticosteroid conjugates
    Patent number: 8796248
    Abstract: The invention provides corticosteroids that are chemically modified by covalent attachment of a water soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits a reduced biological membrane crossing rate as compared to the biological membrane crossing rate of the corticosteroid not attached to the water soluble oligomer.
    Type: Grant
    Filed: October 3, 2008
    Date of Patent: August 5, 2014
    Assignee: Nektar Therapeutics
    Inventors: Wen Zhang, Jennifer Riggs-Sauthier, J. Milton Harris, Michael D. Bentley
  • Oligome-containing pyrrolidine compounds
    Patent number: 8785661
    Abstract: The invention relates to (among other things) oligomer-containing pyrrolidine compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.
    Type: Grant
    Filed: May 13, 2010
    Date of Patent: July 22, 2014
    Assignee: Nektar Therapeutics
    Inventor: Jennifer Riggs-Sauthier
  • OLIGOMER-OPIOID AGONIST CONJUGATES
    Publication number: 20140200235
    Abstract: The invention provides compounds that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from those of the compound not attached to the water-soluble oligomer.
    Type: Application
    Filed: September 20, 2013
    Publication date: July 17, 2014
    Applicant: NEKTAR THERAPEUTICS
    Inventors: Jennifer RIGGS-SAUTHIER, Bo-Liang Deng, Timothy A. Riley
  • Oligomer conjugates of heteropentacyclic nucleosides
    Patent number: 8778898
    Abstract: The invention provides small molecule drugs that are chemically modified by covalent attachment of a water-soluble oligomer.
    Type: Grant
    Filed: May 17, 2013
    Date of Patent: July 15, 2014
    Assignee: Nektar Therapeutics
    Inventors: Bo-Liang Deng, Timothy A. Riley, Jennifer Riggs-Sauthier
  • Oligomer-containing substituted aromatic triazine compounds
    Patent number: 8772479
    Abstract: The invention relates to (among other things) oligomer-containing substituted aromatic triazine compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.
    Type: Grant
    Filed: May 13, 2010
    Date of Patent: July 8, 2014
    Assignee: Nektar Therapeutics
    Inventors: Jennifer Riggs-Sauthier, Bo-Liang Deng
  • OLIGOMER-OPIOID AGONIST CONJUGATES
    Publication number: 20140187790
    Abstract: The invention provides compounds that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from those of the compound not attached to the water-soluble oligomer.
    Type: Application
    Filed: September 20, 2013
    Publication date: July 3, 2014
    Applicant: NEKTAR THERAPEUTICS
    Inventors: Jennifer RIGGS-SAUTHIER, Bo-Liang DENG, Timothy A. RILEY
  • Synthesis of azo bonded immunoregulatory compounds
    Patent number: 8754197
    Abstract: Methods are disclosed for preparing compounds of Formula I: where R1, R3, and R4 are independently hydrogen or C1 to C4 alkyl, and R2 is: where R5 is selected from the group consisting of hydrogen and C1 to C4 alkyl, or where R6, R7 and R8 are independently hydrogen or C1 to C4 alkyl; or the esters or pharmacologically acceptable salts thereof. The compounds and or their metabolites can be used to treat or prevent various diseases, particularly inflammatory conditions of the GI tract.
    Type: Grant
    Filed: November 19, 2012
    Date of Patent: June 17, 2014
    Assignee: Biocon Limited
    Inventors: Jennifer A. Riggs-Sauthier, Nnochiri N. Ekwuribe
  • Oligomer-calcium channel blocker conjugates
    Patent number: 8748648
    Abstract: The invention provides small molecule drugs that are chemically modified by covalent attachment of a water soluble oligomer. A conjugate of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from the characteristics of the small molecule drug not attached to the water soluble oligomer.
    Type: Grant
    Filed: September 3, 2008
    Date of Patent: June 10, 2014
    Assignee: Nektar Therapeutics
    Inventors: Zhongxu Ren, Bo-Liang Deng, Jennifer Riggs-Sauthier, Micah Harvey
  • OLIGOMER-DIARYLPIPERAZINE CONJUGATES
    Publication number: 20140155412
    Abstract: The invention relates to (among other things) oligomer-diarylpiperazine conjugates and related compounds. A conjugate of the invention, when administered by any of a number of administration routes, exhibits advantages over previously administered un-conjugated diarylpiperazine compounds.
    Type: Application
    Filed: February 7, 2014
    Publication date: June 5, 2014
    Applicant: NEKTAR THERAPEUTICS
    Inventors: Zhongxu Ren, Jennifer Riggs-Sauthier
  • Oligomer-nucleoside phosphate conjugates
    Patent number: 8741858
    Abstract: The invention provides small molecule drugs that are chemically modified by covalent attachment of a water soluble, non-peptidic oligomer. The conjugates of the invention, when administered by any of a number of administration routes, exhibits advantages over previously administered compounds.
    Type: Grant
    Filed: September 18, 2008
    Date of Patent: June 3, 2014
    Inventors: Zhongxu Ren, Jennifer Riggs-Sauthier, Timothy A. Riley, Laurie A. VanderVeen, Aaron S. Hammons
  • Oligomer-calcimimetic conjugates and related compounds
    Patent number: 8722732
    Abstract: The invention relates to (among other things) oligomer-calcimimetic conjugates and related compounds. A conjugate of the invention, when administered by any of a number of administration routes, exhibits advantages over previously administered compounds.
    Type: Grant
    Filed: March 28, 2012
    Date of Patent: May 13, 2014
    Assignee: Nektar Therapeutics
    Inventors: Jennifer Riggs-Sauthier, Lin Cheng, David Martin
  • MULTI-ARM POLYMERIC ALKANOATE CONJUGATES
    Publication number: 20140113961
    Abstract: Among other aspects, provided herein are multi-armed polymer conjugates comprising an alkanoate-linker, compositions comprising such conjugates, and related methods of making and administering the same. Methods of treatment employing such conjugates and related uses are also provided. The conjugates are prepared with high drug loading efficiencies.
    Type: Application
    Filed: December 20, 2013
    Publication date: April 24, 2014
    Applicant: NEKTAR THERAPEUTICS
    Inventors: Antoni Kozlowski, Samuel P. McManus, Jennifer Riggs-Sauthier, Xiaoming Shen, Wen Zhang
  • OLIGOMER-TRICYCLIC CONJUGATES
    Publication number: 20140100268
    Abstract: The invention provides small molecule drugs that are chemically modified by covalent attachment of a water-soluble oligomer. A conjugate of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from the characteristics of the small molecule drug not attached to the water-soluble oligomer.
    Type: Application
    Filed: September 6, 2013
    Publication date: April 10, 2014
    Applicant: NEKTAR THERAPEUTICS
    Inventors: Wen Zhang, Xuyuan Gu, Stephanie Allums-Donald, Jennifer Riggs-Sauthier
  • Oligomer-diarylpiperazine conjugates
    Patent number: 8685979
    Abstract: The invention relates to (among other things) oligomer-diarylpiperazine conjugates and related compounds. A conjugate of the invention, when administered by any of a number of administration routes, exhibits advantages over previously administered un-conjugated diarylpiperazine compounds.
    Type: Grant
    Filed: January 22, 2009
    Date of Patent: April 1, 2014
    Assignee: Nektar Therapeutics
    Inventors: Zhongxu Ren, Jennifer Riggs-Sauthier
  • Water-Soluble Polymer-Linked Binding Moiety and Drug Compounds
    Publication number: 20140088021
    Abstract: Compounds comprising a binding moiety, water-soluble, non-peptidic polymer, and drug are provided. Also provided are methods preparing such compounds, compositions comprising such compounds and methods for administering and using such compounds and compositions.
    Type: Application
    Filed: May 24, 2012
    Publication date: March 27, 2014
    Applicant: Nektar Therapeutics
    Inventors: Jennifer Riggs-Sauthier, Deborah H. Charych, Clark Norman Eid, Dennis G. Fry, Marina Konakova, Christine Frances Loehrlein
  • OLIGOMER-PROTEIN TYROSINE KINASE INHIBITOR CONJUGATES
    Publication number: 20140080839
    Abstract: The invention relates to (among other things) oligomer-PTK inhibitor conjugates and related compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits advantages over PTK inhibitor compounds lacking a water-soluble, non-peptidic oligomer.
    Type: Application
    Filed: August 9, 2013
    Publication date: March 20, 2014
    Applicant: Nektar Therapeutics
    Inventors: Jennifer Riggs-Sauthier, Wen Zhang
  • OLIGOMER-PROTEASE INHIBITOR CONJUGATES
    Publication number: 20140045770
    Abstract: The invention provides small molecule drugs that are chemically modified by covalent attachment of a water-soluble oligomer. A conjugate of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from the small molecule drug not attached to the water-soluble oligomer.
    Type: Application
    Filed: October 16, 2013
    Publication date: February 13, 2014
    Applicant: NEKTAR THERAPEUTICS
    Inventors: Jennifer RIGGS-SAUTHIER, Lin Cheng, Tacey X. Viegas, Xuyuan Gu, Franco J. Duarte, Wen Zhang
  • Oligomer-Containing Hydantoin Compounds
    Publication number: 20140039020
    Abstract: The invention relates to (among other things) oligomer-containing hydantoin compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.
    Type: Application
    Filed: December 15, 2011
    Publication date: February 6, 2014
    Applicant: Nektar Therapeutics
    Inventors: Jennifer Riggs-Sauthier, Stephanie Allums-Donald